SEGMENT INFORMATION

12 Months Ended

Mar. 28, 2015

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

Segment Definition Criteria

We manage a global business which designs, manufactures and markets blood management solutions.  Our solutions are marketed through operating segments organized primarily on geography: North America Plasma, North America Blood Center and Hospital, Europe, Asia Pacific and Japan.

ASC 280, Segment Reporting, permits the aggregation of segments which are economically similar as well as similar in all of the following areas: (i) the nature of the products and services, (ii) the nature of the production processes, (iii) the type or class of customer for their products and services, (iv) the methods used to distribute their products or provide their services, and (v) the nature of the regulatory environment.

The Company believes aggregating the operating segments noted above is consistent with the key principles of ASC 280, based on the determination that they are economically similar. The Company believes a single reportable segment is consistent with its basic organizational structure and believes aggregation is consistent with its primary basis for decision making and accordingly does not conflict with the basic principles of ASC 280.

Enterprise Wide Disclosures About Product and Services

We have four global product families: plasma, blood center, hospital, and software solutions.

Our products include whole blood disposables, equipment devices and the related disposables used with these devices. Disposables include part of plasma, blood center, and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components and subsequent collection of plasma to be used as a raw material for biologically derived pharmaceuticals. Blood center consists of disposables which separate whole blood for the subsequent collection of platelets, plasma, red cells, or a combination of these components for transfusion to patients as well as disposables for manual whole blood collection. Hospital consists of surgical disposables (principally the Cell Saver^® autologous blood recovery system targeted to procedures that involve rapid, high volume blood loss such as cardiovascular surgeries), the OrthoPAT^® orthopedic perioperative autotransfusion system designed to operate both during and after surgery to recover and wash the patient’s red cells to prepare them for reinfusion, and diagnostics products (principally the TEG^® Thrombelastograph^® hemostasis analyzer used to help assess a surgical patient’s hemostasis during and after surgery).

Software solutions include information technology platforms that assist blood centers, plasma centers, and hospitals to more effectively manage regulatory compliance and operational efficiency.

Revenues from External Customers:

(In thousands)	March 28, 2015		March 29, 2014		March 30, 2013
Disposable revenues
Plasma disposables	$	319,190	$	291,895	$	268,900
Blood center disposables
Platelet	152,588		156,643		169,602
Red cell	42,700		42,378		49,733
Whole blood	143,905		190,698		138,436
	339,193		389,719		357,771
Hospital disposables
Surgical	62,540		66,876		73,508
OrthoPAT	20,316		25,042		30,230
Diagnostics	42,187		33,302		27,356
	125,043		125,220		131,094
Disposables revenue	783,426		806,834		757,765
Software solutions	72,185		70,441		69,952
Equipment & other	54,762		61,234		64,273
Total revenues	$	910,373	$	938,509	$	891,990

Enterprise Wide Disclosures About Product and Services

Year Ended (in thousands)

March 28, 2015	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Net revenues	$	494,788	$	9,617	$	504,405	$	88,298	$	102,095	$	215,575	$	910,373
Total Assets	$	810,159	$	240,610	$	1,050,769	$	41,621	$	79,084	$	313,943	$	1,485,417
Long-Lived Assets	$	532,187	$	212,548	$	744,735	$	9,230	$	46,857	$	114,318	$	915,140

March 29, 2014	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Net revenues	$	500,719	$	9,557	$	510,276	$	108,679	$	94,762	$	224,792	$	938,509
Total Assets	$	810,409	$	225,998	$	1,036,407	$	53,207	$	53,055	$	371,509	$	1,514,178
Long-Lived Assets	$	519,396	$	211,624	$	731,020	$	11,522	$	17,269	$	131,391	$	891,202

March 30, 2013	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Net revenues	$	454,874	$	6,851	$	461,725	$	120,726	$	84,860	$	224,679	$	891,990
Total Assets	$	830,754	$	225,849	$	1,056,603	$	44,189	$	41,037	$	320,088	$	1,461,917
Long-Lived Assets	$	503,606	$	209,439	$	713,045	$	12,977	$	8,076	$	117,717	$	851,815

The Long-Lived Assets reported above include Goodwill, Intangibles and Net Property, Plant and Equipment.